Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.

Wall DA, Carter SL, Kernan NA, Kapoor N, Kamani NR, Brochstein JA, Frangoul H, Goyal RK, Horan JT, Pietryga D, Wagner JE, Kurtzberg J, COBLT Steering Committee
Biol Blood Marrow Transplant. 2005 11 (8): 637-46

PMID: 16041314 · DOI:10.1016/j.bbmt.2005.05.003

MeSH Terms (21)

Antilymphocyte Serum Antineoplastic Agents, Alkylating Antineoplastic Combined Chemotherapy Protocols Busulfan Child, Preschool Cord Blood Stem Cell Transplantation Disease-Free Survival Female Graft Survival Graft vs Host Disease Histocompatibility Testing Humans Immunosuppressive Agents Infant Infant, Newborn Leukemia Male Melphalan Retrospective Studies Transplantation Conditioning Whole-Body Irradiation

Connections (1)

This publication is referenced by other Labnodes entities:

Links